Stockscreener 앱 받기
3.68
1.38%
0.05
시간 외 거래:
3.61
-0.07
-1.90%
전일 마감가:
$3.63
열려 있는:
$3.7
하루 거래량:
369.42K
Relative Volume:
0.33
시가총액:
$273.16M
수익:
$6.96M
순이익/손실:
$-46.51M
주가수익비율:
-21.45
EPS:
-0.1716
순현금흐름:
$-37.99M
1주 성능:
+0.00%
1개월 성능:
+4.25%
6개월 성능:
+11.18%
1년 성능:
-69.89%
1일 변동 폭
$3.565
$3.75
1주일 범위
$3.47
$3.94
52주 변동 폭
$1.60
$16.55
Perspective Therapeutics Inc Stock (CATX) Company Profile
명칭
Perspective Therapeutics Inc
전화
509-375-1202
주소
350 Hills Street, Suite 106, Richland
CATX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
3.68 | 283.55M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-11-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-01 | 개시 | Wedbush | Outperform |
| 2024-09-25 | 개시 | Truist | Buy |
| 2024-07-25 | 개시 | BofA Securities | Buy |
| 2024-05-09 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스
Perspective Therapeutics, Inc. shares rise 3.09% after-hours following a corporate update on clinical progress and strategic positioning. - AInvest
Published on: 2025-08-04 12:18:12 - Jammu Links News
When is Perspective Therapeutics Inc. stock expected to show significant growthInvest smarter with expert stock recommendations - Jammu Links News
Why is Perspective Therapeutics Inc. stock attracting strong analyst attentionConsistent triple returns - Jammu Links News
What are the technical indicators suggesting about Perspective Therapeutics Inc.Unlock your portfolio’s hidden potential - Jammu Links News
How does Perspective Therapeutics Inc. generate profit in a changing economyBuild wealth steadily with proven methods - Jammu Links News
What are the latest earnings results for Perspective Therapeutics Inc.Unlock rapid growth potential in your portfolio - Jammu Links News
How many analysts rate Perspective Therapeutics Inc. as a “Buy”Build a strong portfolio for long-term success - Jammu Links News
Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy - Seeking Alpha
Perspective Therapeutics (NYSE:CATX) vs. Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
How to read the order book for Perspective Therapeutics Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Perspective Therapeutics Updates Radiopharmaceutical Platform Presentation - TipRanks
Live market analysis of Perspective Therapeutics Inc.Predictive AI Engine for Smart Investing - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
What makes Perspective Therapeutics Inc. stock price move sharplySwing Candidate List with Trade Cues - Newser
When is the best time to exit Perspective Therapeutics Inc.Smart Trade Mapping with Entry Details - Newser
How strong is Perspective Therapeutics Inc. company’s balance sheetTop Growth Tips For Consistent Profits - jammulinksnews.com
Multi factor analysis applied to Perspective Therapeutics Inc.Smart Allocation Stock Pick Insights Gaining Interest - metal.it
Perspective Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowAI Driven Buy Alert Trade Blueprint Released - metal.it
Volume spikes in Perspective Therapeutics Inc. stock – what they meanSector Rotation Outlook With Historical Summary - Newser
Is It Too Late to Sell Perspective Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
Perspective Therapeutics shares fall 3.16% intraday after FDA approval conference call for Sephience. - AInvest
Is Perspective Therapeutics Inc. the Top Chart Pick This WeekCommunity Strategy With High Win Rate Backtested - metal.it
How volatile is Perspective Therapeutics Inc. stock compared to the marketFinancial News Outlook For 2025 - jammulinksnews.com
Is it the right time to buy Perspective Therapeutics Inc. stockAI Powered Target Finder For Consistent Profits - Jammu Links News
What is the dividend policy of Perspective Therapeutics Inc. stockStock Market Review That Work - Jammu Links News
Perspective Therapeutics shares fall 1.48% premarket after Unicycive Therapeutics receives FDA CRL. - AInvest
Volume spikes in Perspective Therapeutics Inc. stock – what they mean Asset Growth Pattern and Return Summary - Newser
What is the risk reward ratio of investing in Perspective Therapeutics Inc. stockInvest with confidence backed by data - Jammu Links News
Published on: 2025-07-27 16:42:40 - Jammu Links News
Perspective Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Predictions - Newser
Moving Average Trends for Perspective Therapeutics Inc. Stock: What They IndicateSmart High Yield Swing Trades - Newser
How Perspective Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser
What analysts say about Perspective Therapeutics Inc. stockTriple returns potential - PrintWeekIndia
What drives Perspective Therapeutics Inc. stock priceBreakthrough financial growth - PrintWeekIndia
Is Perspective Therapeutics Inc. a good long term investmentFree Buy/Sell Signal Notifications - Autocar Professional
Should I buy Perspective Therapeutics Inc. stock before earningsOutstanding capital returns - Jammu Links News
Perspective Therapeutics Inc (CATX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):